<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Beer M</submitter><funding>BLRD VA</funding><funding>Cleveland Department of Veterans Affairs</funding><funding>European Research Council</funding><funding>Biotechnology and Biological Sciences Research Council</funding><funding>Engineering and Physical Sciences Research Council</funding><pagination>3284-3300</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12643063</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>599(22)</volume><pubmed_abstract>β-Lactamase-catalysed hydrolysis is the primary form of β-lactam antibiotic resistance in Gram-negative bacteria. The penicillanic acid sulfone (PAS) enmetazobactam is thought to inhibit extended-spectrum β-lactamases (ESBLs) by fragmentation of an initial acyl-enzyme to form an active-site lysinoalanine cross link. We investigate interactions of enmetazobactam and its congener tazobactam with GES-1, an ESBL with structural features of carbapenem-hydrolysing β-lactamases. Crystal structures show different breakdown products of the two inhibitors covalently bound to the catalytic Ser70, assigned using quantum mechanics/molecular mechanics (QM/MM) calculations. We find no evidence for lysinoalanine formation, with mass spectrometry indicating active enzyme regeneration, behaviour previously </pubmed_abstract><journal>FEBS letters</journal><pubmed_title>Mechanistic basis for inhibition of the extended-spectrum β-lactamase GES-1 by enmetazobactam and tazobactam.</pubmed_title><pmcid>PMC12643063</pmcid><funding_grant_id>BB/M026280/1</funding_grant_id><funding_grant_id>BB/T008741/1</funding_grant_id><funding_grant_id>1I01BX001974</funding_grant_id><funding_grant_id>EP/W013738/1</funding_grant_id><funding_grant_id>I01 BX001974</funding_grant_id><funding_grant_id>101021207</funding_grant_id><pubmed_authors>Papp-Wallace KM</pubmed_authors><pubmed_authors>Beer M</pubmed_authors><pubmed_authors>Mulholland AJ</pubmed_authors><pubmed_authors>Spencer J</pubmed_authors><pubmed_authors>Bethel CR</pubmed_authors><pubmed_authors>Shapiro S</pubmed_authors><pubmed_authors>Hinchliffe P</pubmed_authors><pubmed_authors>Hanzevacki M</pubmed_authors><pubmed_authors>Tooke CL</pubmed_authors><pubmed_authors>Van der Kamp MW</pubmed_authors><pubmed_authors>Bonomo RA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mechanistic basis for inhibition of the extended-spectrum β-lactamase GES-1 by enmetazobactam and tazobactam.</name><description>β-Lactamase-catalysed hydrolysis is the primary form of β-lactam antibiotic resistance in Gram-negative bacteria. The penicillanic acid sulfone (PAS) enmetazobactam is thought to inhibit extended-spectrum β-lactamases (ESBLs) by fragmentation of an initial acyl-enzyme to form an active-site lysinoalanine cross link. We investigate interactions of enmetazobactam and its congener tazobactam with GES-1, an ESBL with structural features of carbapenem-hydrolysing β-lactamases. Crystal structures show different breakdown products of the two inhibitors covalently bound to the catalytic Ser70, assigned using quantum mechanics/molecular mechanics (QM/MM) calculations. We find no evidence for lysinoalanine formation, with mass spectrometry indicating active enzyme regeneration, behaviour previously </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-05T16:51:50.471Z</modification><creation>2026-05-19T03:11:56.287Z</creation></dates><accession>S-EPMC12643063</accession><cross_references><pubmed>40944392</pubmed><doi>10.1002/1873-3468.70155</doi></cross_references></HashMap>